Columbus Venture Partners successfully completes the sale of Syngoi Technologies to U.S. based Artis BioSolutions

by Columbus Venture Partners

Syngoi Technologies has developed in recent years its own enzymatic synthetic DNA platform, designed to address one of the key structural challenges in the gene and cell therapy industry: the efficien...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

ARCANO advised Dental Company and its sh...

by Arcano Corporate SLU

Dental Company has established itself as one of the leading dental net...

Photos Stream